# Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium

> **NCT03158311** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 1426 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** QVM149
- **DRUG:** Salmeterol/fluticasone plus tiotropium

## Key facts

- **NCT ID:** NCT03158311
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-05
- **Primary completion:** 2019-07-12
- **Final completion:** 2019-07-19
- **Target enrollment:** 1426 (ACTUAL)
- **Last updated:** 2021-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03158311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03158311, "Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03158311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*